March 26, 2018 — Auris Health Inc. announced U.S. Food and Drug Administration (FDA) clearance of the company’s Monarch Platform. The Monarch Platform integrates the latest advancements in robotics, software, data science and endoscope innovation, with the goal of improving patient outcomes, enhancing physician capabilities, and lowering costs to the healthcare system.

March 26, 2018 — Radiotherapy treatment to part of the breast or a reduced dose to the whole breast yields fewer moderate or marked side effects as reported by breast cancer patients, according to new findings, compared to standard radiotherapy to the whole breast.

Samsung NeuroLogica announced the Samsung RS85A ultrasound system has received U.S. Food and Drug Administration (FDA) 510(k) clearance and will be unveiled at the American Institute of Ultrasound in Medicine (AIUM) in New York City, March 24-28, 2018. The RS85A is a premium general imaging with superior image quality and usability, according to Samsung NeuroLogica President and CEO Philip Sullivan.

March 26, 2018 — Healthcare professionals seeking a cost-effective imaging solution without compromising image quality can now leverage the newly U.S. Food and Drug Administration (FDA)-cleared Aplio i600 ultrasound system from Canon Medical Systems USA Inc. Combined with a full host of easy-to-use workflow tools and performance features, the Aplio i600 improves diagnostic confidence and enables clinicians to deliver quick, reliable exams, according to Canon.

Subscribe Now